AS lulus pil baharu turunkan paras kolestrol

WIRE — WASHINGTON: Pentadbiran Makanan dan Ubat-Ubatan Amerika Syarikat (FDA) meluluskan sejenis pil harian yang mampu menurunkan paras kolesterol ke tahap yang jauh lebih rendah berbanding ubat statin, iaitu ubat penurun kolesterol yang digunakan secara meluas. Ubat enlicitide, yang dipasarkan dengan jenama Lipfendra, dihasilkan oleh syarikat farmaseutikal Merck. Ujian klinikal menunjukkan enlicitide mampu menurunkan paras kolesterol lipoprotein ... Read more The post AS lulus pil baharu turunkan paras kolestrol appeared first on Utusan Malaysia.

"We aggregate wires to encourage regional discovery, sending readers directly back to the original source to explore full coverage."

This is a normalized overview of the breaking feed event. The complete, official release detailing all points, background context, and statements remains hosted by the original publisher.